Transmission of ceftazidime-avibactam-resistant Escherichia coli among pets, veterinarians and animal hospital environment

• Main Authors: Hegen Dai (Author), Dongyan Shao (Author), Yu Song (Author), Qi An (Author), Zhenbiao Zhang (Author), Haixia Zhang (Author), Siyu Chen (Author), Congming Wu (Author), Jianzhong Shen (Author), Yanli Lyu (Author), Yang Wang (Author), Shizhen Ma (Author), Zhaofei Xia (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ceftazidime-avibactam (CZA) is a recently approved combination synthetic β-lactamase inhibitor used in human clinical medicine. Cases of CZA resistance in humans have already been reported, but limited research has investigated CZA resistance in pets. This study explored the prevalence and transmiss...